17 results
424B3
NTBL
Notable Labs Ltd
5 Sep 23
Prospectus supplement
6:02pm
members of the health care community of the effectiveness and safety of Notable’s drugs for their indicated applications and treatments;
Notable’s … , will be accepted by physicians, hospitals and other health care facilities. Volasertib and Fosciclopirox and any future drug candidates Notable develop
S-4/A
0x0kw tnlcr51fz63d4b
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
EX-10.9
f4qw5wkqssjjidsn enn
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
y1xlov29bjyn78 44
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-99.2
asaxhplx rpxknt
2 Jun 22
Notice of Annual General Meeting of Shareholders
5:00pm
6-K
EX-1.1
q339xt
11 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.2
6yu5 65iaochjxy
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am
6-K
EX-99.1
4ygpx 71gyhut9e
8 Jul 21
VBL Therapeutics Appoints Alison Finger and Michael Rice to its Board of Directors
4:05pm
6-K
EX-1.1
9s1lnavphvkpi jh
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
20-F
EX-4.18
7thhf0mg933v83 zv
25 Mar 15
Annual report (foreign)
12:00am
- Prev
- 1
- Next